Search Query :
3M2W
Crystal structure of mapkak kinase 2 (mk2) complexed with a spiroazetidine-tetracyclic atp site inhibitor Deposition Author(s): Be, C. , Huppertz, C. , Izaac, A. , Kroemer, M. , Revesz, L. , Scheufler, C. , Schlapbach, A.
Date: 2010-03-08 Method: X-RAY DIFFRACTION Resolution: 2.41 Å Organism(s): Homo Sapiens Sequences Data: 3M2W_A
3M42
Crystal structure of mapkap kinase 2 (mk2) complexed with a tetracyclic atp site inhibitor Deposition Author(s): Be, C. , Huppertz, C. , Izaac, A. , Kroemer, M. , Revesz, L. , Scheufler, C. , Schlapbach, A.
Date: 2010-03-10 Method: X-RAY DIFFRACTION Resolution: 2.68 Å Organism(s): Homo Sapiens Sequences Data: 3M42_A
3UGC
Structural basis of jak2 inhibition by the type ii inhibtor nvp-bbt594 Deposition Author(s): Kroemer, M. , Manley, P.W. , Pissot-Soldermann, C. , Scheufler, C. , Tavares, G.A.
Date: 2011-11-02 Method: X-RAY DIFFRACTION Resolution: 1.34 Å Organism(s): Homo Sapiens Sequences Data: 3UGC_A
4MTA
Crystal structure of pim-1 kinase domain in complex with 2-methyl-5-phenylfuran-3-carboxylic acid Deposition Author(s): Be, C. , Scheufler, C.
Date: 2013-09-19 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 4MTA_A
5DRT
Crystal structure of dot1l in complex with inhibitor cpd2 [2-(2-(5-((2-chlorophenoxy)methyl)-1h-tetrazol-1-yl)acetyl)-n-(4-chlorophenyl)hydrazinecarboxamide] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-16 Method: X-RAY DIFFRACTION Resolution: 2.69 Å Organism(s): Homo Sapiens Sequences Data: 5DRT_A , 5DRT_B
5DRY
Crystal structure of dot1l in complex with inhibitor cpd3 [n-(1-(2-chlorophenyl)-1h-indol-6-yl)-2-(2-(5-(2-chlorophenyl)-1h-tetrazol-1-yl)acetyl)hydrazinecarboxamide] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-16 Method: X-RAY DIFFRACTION Resolution: 2.41 Å Organism(s): Homo Sapiens Sequences Data: 5DRY_A , 5DRY_B
5DSX
Crystal structure of dot1l in complex with inhibitor cpd10 [6'-chloro-1,4-dimethyl-5'-(2-methyl-6-((4-(methylamino)pyrimidin-2-yl)amino)-1h-indol-1-yl)-[3,3'-bipyridin]-2(1h)-one] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-17 Method: X-RAY DIFFRACTION Resolution: 2.41 Å Organism(s): Homo Sapiens Sequences Data: 5DSX_A , 5DSX_B
5DT2
Crystal structure of dot1l in complex with inhibitor cpd11 [n4-methyl-n2-(2-methyl-1-(2-phenoxyphenyl)-1h-indol-6-yl)pyrimidine-2,4-diamine] Deposition Author(s): Be, C. , Gaul, C. , Moebitz, H. , Scheufler, C.
Date: 2015-09-17 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 5DT2_A , 5DT2_B
5DTM
Crystal structure of dot1l in complex with inhibitor cpd1 [4-(2,6-dichlorobenzoyl)-n-methyl-1h-pyrrole-2-carboxamide] Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2015-09-18 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 5DTM_A , 5DTM_B
5DTQ
Crystal structure of dot1l in complex with inhibitor cpd3 [(2,6-dichlorophenyl)(quinolin-6-yl)methanone] Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2015-09-18 Method: X-RAY DIFFRACTION Resolution: 2.61 Å Organism(s): Homo Sapiens Sequences Data: 5DTQ_A , 5DTQ_B